MyPharmacy+

Envisa Tablet

Manufactured By Zivira Labs Pvt Ltd

Salt Synonyms

Rs. 244.80

MRP 272.00

(10% OFF)

Includes all taxes

Package SIZE

strip of 10 tablets

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Envisa Tablet

Uses / Indications:

As directed by the physician

Introduction:

Envisa Tablet is a powerful detoxifying agent and a master antioxidant. It helps promote intracellular antioxidant support supports immune functions helps neutralise toxins before they are absorbed and supports healthy function of the liver and kidneys. It is suitable for both men and women.

How to use:

It supports immune function and regenerates vitamins C and E|It helps in tissue building and repair and plays an important role in maintaining a healthy immune system|These capsules are a powerful detoxification agent and master antioxidant|It helps to promote intracellular antioxidant support|It helps in tissue building and repair and plays an important role in maintaining a healthy immune system

Description:

Supports in the making of DNA the building blocks of proteins and cells|Protects the body from the damaging effects of free radicals|Helps in breaking down free radicals and supports certain enzymes function

Benefits:

Safety Advise:

Envisa Tablet

Manufactured By Zivira Labs Pvt Ltd

Salt Synonyms

Rs. 244.80

MRP 272.00

Includes all taxes

Package SIZE

Available Substitutes

1MD Nutrition Alpha-Lipoic Acid Capsule

1MD Nutrition

1MD Nutrition L-Arginine+ Tablet

1MD Nutrition

5 Pro Active Protein Powder Vanilla Toffee

Nouvelle Pharmaceuticals

Erise-LC Tablet

Qcl Life Science Pvt Ltd

Erizyne-Q10 Softgel Capsule

Eridanus Healthcare

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: